• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT POINT OF CARE I-STAT ACT CELITE CARTRIDGE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT POINT OF CARE I-STAT ACT CELITE CARTRIDGE Back to Search Results
Catalog Number 03P86-25
Medical Device Problem Code Incorrect, Inadequate or Imprecise Result or Readings (1535)
Health Effect - Clinical Code Chest Pain (1776)
Date of Event 02/21/2019
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
(b)(4).Apoc labeling will be evaluated during the investigation as pertaining to the event.
 
Event or Problem Description
On (b)(6) 2019, abbott point of care was contacted by a customer regarding act celite cartridges that yielded unexpected results on a (b)(6) female patient with chest pain.There was no patient information available at the time of this report.Return product is not available for investigation.(b)(6).There are no injuries associated with this event.At this time there is no reason to suspect a malfunction exists.The reporting decision was based on the limited information available that suggests the product was not performing within the variability of the assay.There was no baseline tests and limited patient, details about the event.There is no explanation as to how the results would go from 424 to 188 seconds in 8 minutes.The customer did not provide protamine information.It is suspected that protamine was administered but time and dose was not reported.The customer stated that procedure was completed as planned and the patient was discharged.The investigation is underway.
 
Additional Manufacturer Narrative
Apoc incident #: (b)(4).The investigation was completed on 05/01/2019.A review of the device history record (dhr) confirmed that the cartridge lot passed release specifications.Retained cartridge testing of act celite cartridge lot r18339 met the acceptance criteria outlined in appendix 1 of q04.01.003 rev.Ac (product complaint level 2 and level 3 investigation procedure).No deficiency has been identified for act celite cartridge lot r18339.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
I-STAT ACT CELITE CARTRIDGE
Common Device Name
ACT CELITE CARTRIDGE
Manufacturer (Section D)
ABBOTT POINT OF CARE
400 college road
princeton NJ 08540 6607
MDR Report Key8456237
Report Number2245578-2019-00067
Device Sequence Number14162979
Product Code JBP
UDI-Device Identifier10054749000149
UDI-Public10054749000149
Combination Product (Y/N)N
Initial Reporter StateOH
Initial Reporter CountryUS
PMA/510(K) Number
K023571
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source health professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 05/07/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date06/03/2019
Device Catalogue Number03P86-25
Device Lot NumberR18339
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 02/28/2019
Supplement Date Received by Manufacturer05/01/2019
Initial Report FDA Received Date03/27/2019
Supplement Report FDA Received Date05/07/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient Age69 YR
-
-